<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-5044</journal-id>
<journal-title><![CDATA[Revista mexicana de neurociencia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. neurocienc.]]></abbrev-journal-title>
<issn>1665-5044</issn>
<publisher>
<publisher-name><![CDATA[Academia Mexicana de Neurología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-50442025000400003</article-id>
<article-id pub-id-type="doi">10.24875/rmn.24000069</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Knowledge, attitudes, and barriers toward deep brain stimulation for Parkinson&#8217;s disease in Mexico]]></article-title>
<article-title xml:lang="es"><![CDATA[Conocimiento, actitudes y barreras hacia la estimulación cerebral profunda para Parkinson en México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez-Ramírez]]></surname>
<given-names><![CDATA[Daniel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Diaz-Martinez]]></surname>
<given-names><![CDATA[Armando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Dávila-García]]></surname>
<given-names><![CDATA[Mirna E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tapia-Rodríguez]]></surname>
<given-names><![CDATA[Daniel F.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amezcua-Gómez]]></surname>
<given-names><![CDATA[Pedro A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sánchez-Ramírez]]></surname>
<given-names><![CDATA[Karen I.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-González]]></surname>
<given-names><![CDATA[Mirna]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Escuela de Medicina y Ciencias de la Salud Tecnologico de Monterrey ]]></institution>
<addr-line><![CDATA[Monterrey ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de Nuevo León, Hospital Universitario &#8220;Dr. José Eleuterio González&#8221; Departamento de Neurocirugía y Terapia Endovascular Neurológica ]]></institution>
<addr-line><![CDATA[Monterrey ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Regional Manuel Cárdenas de la Vega Departamento de Calidad e Investigación ]]></institution>
<addr-line><![CDATA[Sinaloa ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2025</year>
</pub-date>
<volume>26</volume>
<numero>4</numero>
<fpage>113</fpage>
<lpage>119</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-50442025000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-50442025000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-50442025000400003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: Parkinson&#8217;s disease (PD) is the second most prevalent neurodegenerative disorder among individuals over 50 years old and poses a significant public health challenge in Mexico. While deep brain stimulation (DBS) is an effective therapy for improving motor symptoms and reducing medication dependency, its adoption in Mexico faces multiple barriers. This study aimed to evaluate the knowledge, attitudes, and perceived barriers among physicians regarding DBS to identify key areas for optimizing its accessibility for PD patients.  Methods: A descriptive qualitative study was conducted using a 19-question online survey targeting Mexican physicians who treat patients with PD. A total of 69 physicians from various specialties participated. Data were analyzed using descriptive statistics and thematic analysis.  Results: Among respondents, 89.9% considered DBS to be safe, and 94.2% did not perceive it as a last resort treatment. However, 71.0% lacked specialized training in DBS, and 34.8% had no contact with specialized DBS centers. The main reported barriers included the high cost of the procedure (79.7%), centralization of services in major cities (29%), and limited knowledge among physicians and patients (21.7%).  Conclusions: Despite favorable attitudes toward DBS in Mexico, economic, educational, and infrastructural barriers hinder its implementation. It is crucial to develop funding policies, decentralize services, and strengthen medical training to ensure equitable and timely access to this advanced therapy.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: La enfermedad de Parkinson (EP) es el segundo trastorno neurodegenerativo más prevalente en mayores de 50 años y representa un desafío significativo para la salud pública en México. Aunque la estimulación cerebral profunda (ECP) es una terapia eficaz para mejorar los síntomas motores y reducir la dependencia de medicamentos, su adopción en México enfrenta múltiples barreras. Este estudio tuvo como objetivo evaluar el conocimiento, las actitudes y las barreras percibidas entre los médicos respecto a la ECP para identificar áreas clave que optimicen su accesibilidad para los pacientes con EP.  Métodos:: Se realizó un estudio descriptivo cualitativo mediante una encuesta en línea de 19 preguntas dirigida a médicos mexicanos que atienden pacientes con EP. Participaron 69 médicos de diversas especialidades. Los datos fueron analizados utilizando estadísticas descriptivas y análisis temático.  Resultados: El 89.9% de los encuestados consideró que la ECP es segura, y el 94.2% no la percibe como una terapia de última línea. Sin embargo, el 71.0% carecía de capacitación especializada en ECP, y el 34.8% no tenía contacto con centros especializados. Las principales barreras reportadas incluyeron el alto costo del procedimiento (79.7%), la centralización de los servicios en ciudades principales (29%) y el conocimiento limitado entre médicos y pacientes (21.7%).  Conclusiones: A pesar de las actitudes favorables hacia la ECP en México, las barreras económicas, educativas y de infraestructura dificultan su implementación. Es fundamental desarrollar políticas de financiamiento, descentralizar servicios y fortalecer la capacitación médica para garantizar un acceso equitativo y oportuno a esta terapia avanzada.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Parkinson&#8217;s disease]]></kwd>
<kwd lng="en"><![CDATA[Deep brain stimulation]]></kwd>
<kwd lng="en"><![CDATA[Access barriers]]></kwd>
<kwd lng="en"><![CDATA[Medical attitudes]]></kwd>
<kwd lng="en"><![CDATA[Mexico]]></kwd>
<kwd lng="es"><![CDATA[Enfermedad de Parkinson]]></kwd>
<kwd lng="es"><![CDATA[Estimulación cerebral profunda]]></kwd>
<kwd lng="es"><![CDATA[Barreras de acceso]]></kwd>
<kwd lng="es"><![CDATA[Actitudes médicas]]></kwd>
<kwd lng="es"><![CDATA[México]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodriguez-Violante]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Velasquez-Perez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cervantes-Arriaga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence rates of Parkinson's disease in Mexico:analysis of 2014-2017 statistics]]></article-title>
<source><![CDATA[Rev Mex Neuroci]]></source>
<year>2019</year>
<volume>20</volume>
<page-range>136-40</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Deliz]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Tanner]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez-Latapi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of Parkinson's disease:an update]]></article-title>
<source><![CDATA[Curr Neurol Neurosci Rep]]></source>
<year>2024</year>
<volume>24</volume>
<page-range>163-79</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaudhuri]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Sauerbier]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parkinson disease. Unravelling the nonmotor mysteries of Parkinson disease]]></article-title>
<source><![CDATA[Nat Rev Neurol]]></source>
<year>2016</year>
<volume>12</volume>
<page-range>10-1</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yoritaka]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shimo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Hatano]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hattori]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Motor/nonmotor symptoms and progression in patients with Parkinson's disease:prevalence and risks in a longitudinal study]]></article-title>
<source><![CDATA[Parkinsons Dis]]></source>
<year>2020</year>
<volume>2020</volume>
<page-range>2735361</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aradi]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Hauser]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical management and prevention of motor complications in Parkinson's disease]]></article-title>
<source><![CDATA[Neurotherapeutics]]></source>
<year>2020</year>
<volume>17</volume>
<page-range>1339-65</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cavallieri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mulroy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The history of deep brain stimulation]]></article-title>
<source><![CDATA[Parkinsonism Relat Disord]]></source>
<year>2024</year>
<volume>121</volume>
<page-range>105980</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bove]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mulas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Cavallieri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Castrioto]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chabardes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meoni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2021</year>
<volume>97</volume>
<page-range>e254-62</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[Han C]]></given-names>
</name>
<name>
<surname><![CDATA[Ostendorf]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Jimenez-Shahed]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sarva]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurologists'attitudes toward use and timing of deep brain stimulation]]></article-title>
<source><![CDATA[Neurol Clin Pract]]></source>
<year>2021</year>
<volume>11</volume>
<page-range>506-16</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez-Ramirez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Okun]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rationale and clinical pearls for primary care doctors referring patients for deep brain stimulation]]></article-title>
<source><![CDATA[Gerontology]]></source>
<year>2014</year>
<volume>60</volume>
<page-range>38-48</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bronstein]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Tagliati]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alterman]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Volkmann]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stefani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deep brain stimulation for Parkinson disease:an expert consensus and review of key issues]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2011</year>
<volume>68</volume>
<page-range>165</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shih]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Tarsy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survey of U. S. neurologists'attitudes towards deep brain stimulation for Parkinson's disease]]></article-title>
<source><![CDATA[Neuromodulation]]></source>
<year>2011</year>
<volume>14</volume>
<page-range>208-13</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lange]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mauerer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Schlaier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Janzen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zeman]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bogdahn]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Underutilization of deep brain stimulation for Parkinson's disease?A survey on possible clinical reasons]]></article-title>
<source><![CDATA[Acta Neurochir (Wien)]]></source>
<year>2017</year>
<volume>159</volume>
<page-range>771-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
